Abbott Laboratories
Change company Symbol lookup
Select an option...
ABT Abbott Laboratories
HHDS Highlands REIT Inc
PATK Patrick Industries Inc
ICD Independence Contract Drilling Inc
EAC Edify Acquisition Corp
ABNAF Aben Resources Ltd
PITPY Indocement Tunggal Prakarsa Tbk PT
OPEN Opendoor Technologies Inc
CNX CNX Resources Corp
BYOC Beyond Commerce Inc
Go

Health Care : Health Care Equipment & Supplies | Large Cap Blend
Company profile

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.

Closing Price
$125.13
Day's Change
0.26 (0.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
126.78
Day's Low
125.10
Volume
(Average)
Volume:
4,918,788

10-day average volume:
4,807,466
4,918,788

Latest Earnings (Q2 ending 06/2021)

Q2
$1.17
Q2 Consensus estimate
$1.02

Latest Earnings Estimate Range

Highest
estimate
$1.07
Mean
estimate
$1.02
Lowest
estimate
$0.98

Quarterly Consensus Estimates and Ranges

ABT's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.